论文部分内容阅读
妇科恶性肿瘤是严重危害妇女健康的常见疾病之一,尤其是卵巢癌有逐年增加趋势,早期诊断困难,预后不良,死亡率居妇科肿瘤之首[1]。因此,卵巢癌的早期诊断,是关键,为避免癌抗原125(CA-125)单项检测在诊断中的局限性,提高肿瘤标志物的可信度。联合检测CA-125和肿瘤相关物质(TSGF),
Gynecologic malignancies are one of the most common diseases which seriously endanger the health of women. Especially ovarian cancer has a tendency of increasing year by year. Early diagnosis is difficult and prognosis is poor. The mortality rate is the highest in gynecologic tumors [1]. Therefore, the early diagnosis of ovarian cancer is the key. In order to avoid the limitations of single diagnosis of CA125, the reliability of tumor markers should be improved. Combined detection of CA-125 and tumor-associated substances (TSGF)